These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22351285)

  • 1. Immunogenetics and Life-Span : HLA.
    Middleton D; Curran MD; Williams F
    Methods Mol Med; 2000; 38():321-49. PubMed ID: 22351285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human major histocompatibility complex: the HLA system].
    Charron D; Khalil I
    Rev Prat; 1994 Jan; 44(1):20-7. PubMed ID: 8178053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biology of the HLA class I and class II genes.
    Wake CT
    Mol Biol Med; 1986 Feb; 3(1):1-11. PubMed ID: 3083191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenetics of chronic ulcerative colitis].
    Yamamoto-Furusho JK
    Rev Invest Clin; 2003; 55(6):705-10. PubMed ID: 15011740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.
    Shichi D; Kikkawa EF; Ota M; Katsuyama Y; Kimura A; Matsumori A; Kulski JK; Naruse TK; Inoko H
    Tissue Antigens; 2005 Sep; 66(3):200-8. PubMed ID: 16101831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human major histocompatibility complex and childhood leukemia: an etiological hypothesis based on molecular mimicry.
    Taylor M; Hussain A; Urayama K; Chokkalingam A; Thompson P; Trachtenberg E; Buffler P
    Blood Cells Mol Dis; 2009; 42(2):129-35. PubMed ID: 19054700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease.
    Gregersen PK
    Lab Invest; 1989 Jul; 61(1):5-19. PubMed ID: 2664347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II transgenic mice mimic human inflammatory diseases.
    Mangalam AK; Rajagopalan G; Taneja V; David CS
    Adv Immunol; 2008; 97():65-147. PubMed ID: 18501769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human major histocompatibility complex. Genes and diseases.
    Krzanowski JJ
    J Fla Med Assoc; 1992 Feb; 79(2):97-9. PubMed ID: 1552300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease.
    Bugawan TL; Angelini G; Larrick J; Auricchio S; Ferrara GB; Erlich HA
    Nature; 1989 Jun; 339(6224):470-3. PubMed ID: 2498667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antigen presentation and macrophages].
    Toubert A; Charron D
    Pathol Biol (Paris); 1997 Feb; 45(2):126-30. PubMed ID: 9247034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
    Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
    Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene structure of the human MHC region].
    Mizuki N; Kimura M
    Nihon Rinsho; 1996 Jun; 54(6):1705-17. PubMed ID: 8691633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells.
    Fling SP; Arp B; Pious D
    Nature; 1994 Apr; 368(6471):554-8. PubMed ID: 8139690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The major histocompatibility complex and autoimmunity.
    Chaplin DD; Kemp ME
    Year Immunol; 1988; 3():179-98. PubMed ID: 3327310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma.
    Booman M; Douwes J; Glas AM; Riemersma SA; Jordanova ES; Kok K; Rosenwald A; de Jong D; Schuuring E; Kluin PM
    Clin Cancer Res; 2006 May; 12(9):2698-705. PubMed ID: 16675561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism and evolution of HLA class I and II genes and molecules.
    Little AM; Parham P
    Rev Immunogenet; 1999; 1(1):105-23. PubMed ID: 11256568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin.
    Stemme S; Fager G; Hansson GK
    Immunology; 1990 Feb; 69(2):243-9. PubMed ID: 2106484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.